Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.16 USD | -0.19% | -7.07% | -41.35% |
04:00am | Zai Lab Reports Lesser Loss in 2023 | MT |
Mar. 27 | Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients | MT |
Financials (USD)
Sales 2024 * | 378M | Sales 2025 * | 614M | Capitalization | 1.6B |
---|---|---|---|---|---|
Net income 2024 * | -307M | Net income 2025 * | -170M | EV / Sales 2024 * | 2.93 x |
Net cash position 2024 * | 491M | Net cash position 2025 * | 275M | EV / Sales 2025 * | 2.16 x |
P/E ratio 2024 * |
-5.1
x | P/E ratio 2025 * |
-8.57
x | Employees | 2,175 |
Yield 2024 * |
-
| Yield 2025 * |
1.24% | Free-Float | 97.22% |
Latest transcript on Zai Lab Limited
1 day | +1.50% | ||
1 week | -5.93% | ||
Current month | -22.83% | ||
1 month | -28.01% | ||
3 months | -37.85% | ||
6 months | -35.91% | ||
Current year | -40.76% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 59 | 14-03-31 |
Ya jing Chen
DFI | Director of Finance/CFO | 56 | 21-08-31 |
Joshua Smiley
PSD | President | 54 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John D. Diekman
BRD | Director/Board Member | 81 | 16-12-31 |
Peter Wirth
BRD | Director/Board Member | 73 | 16-12-31 |
Lonnie Moulder
BRD | Director/Board Member | 66 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.29% | 4 M€ | -27.92% | ||
1.04% | 2 M€ | -16.04% | - | |
0.75% | 96 M€ | -.--% | - | |
0.27% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 16 | -1.14% | 182 079 |
24-03-27 | 16.19 | +1.50% | 1,037,425 |
24-03-26 | 15.95 | -1.85% | 803,949 |
24-03-25 | 16.25 | +0.43% | 634,339 |
24-03-22 | 16.18 | -6.20% | 782,189 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.76% | 1.6B | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.30% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |